Definition of Melanoma
Melanoma is a malignant neoplasm arising from melanocytes, most commonly originating in the skin (cutaneous melanoma), but can also develop in mucosal membranes, the uveal tract of the eye, or leptomeninges. 1
Core Pathologic Definition
Melanoma represents a malignant tumor derived from melanocytes that initially proliferates as atypical melanocytes within the epidermis 2, 3. The disease follows a characteristic progression pattern:
- Radial Growth Phase (RGP): Initial non-tumorigenic phase confined to the epidermis or papillary dermis, lacking metastatic potential
- Vertical Growth Phase (VGP): Tumorigenic phase with deeper dermal extension, nodular confluence, mitotic activity, and metastatic capacity 3
Important exception: Nodular melanoma either rapidly progresses through RGP or arises directly from dermal melanocytes, bypassing the typical progression pattern 3.
Anatomic Classification
Cutaneous Melanoma (Most Common)
The vast majority (80-90%) arise de novo rather than from pre-existing nevi 1. Primary subtypes include:
- Superficial spreading melanoma (most common)
- Nodular melanoma
- Lentigo maligna melanoma (associated with chronic sun exposure)
- Acral lentiginous melanoma (palms, soles, subungual sites)
- Desmoplastic melanoma
Non-Cutaneous Melanomas
These are distinct diseases from cutaneous melanoma with different presentations, genetic profiles, staging systems, treatment responses, and progression patterns 1:
- Mucosal melanomas: head/neck sinuses, oral cavity, anorectum, vulva, vagina, gastrointestinal and genitourinary tracts
- Uveal melanoma: arising from the uveal tract of the eye
- Leptomeningeal melanoma
Critical caveat: Cutaneous melanoma is NOT a risk factor for uveal or mucosal melanoma—these should be managed as separate disease entities 1.
Clinical Significance
Melanoma represents the most dangerous form of skin cancer, accounting for 90% of skin cancer mortality despite being less common than other skin cancers 4. Prognosis is primarily determined by Breslow depth (tumor thickness), which remains the single most important prognostic factor for clinically localized disease 3:
- Ultra-thin: ≤0.5 mm
- Thin: ≤1 mm
- Thick: >1 mm
- Ultra-thick: >6 mm
Key pathologic principle: Some thin melanomas behave aggressively because they possess an early tumorigenic vertical growth phase despite limited thickness 3.